Amedeo Smart

Free Medical Literature Service


 

Amedeo

Cytomegalovirus Infection

  Free Subscription

Articles published in
J Infect Dis
    March 2024
  1. FIERRO C, Brune D, Shaw M, Schwartz H, et al
    Safety and Immunogenicity of a Messenger RNA-Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1, Randomized, Clinical Trial.
    J Infect Dis. 2024 Mar 13:jiae114. doi: 10.1093.
    >> Share

    February 2024
  2. HU X, Karthigeyan KP, Herbek S, Valencia SM, et al
    Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine.
    J Infect Dis. 2024 Feb 7:jiad593. doi: 10.1093.
    >> Share

    January 2024
  3. VENTURINI C, Colston JM, Charles O, Lankina A, et al
    Persistent low-level variants in a subset of viral genes are highly predictive of poor outcome in immunocompromised patients with cytomegalovirus infection.
    J Infect Dis. 2024 Jan 5:jiae001. doi: 10.1093.
    >> Share

    September 2023
  4. FERNANDEZ-RUIZ M, Garcia-Rios E, Redondo N, Rodriguez-Goncer I, et al
    Post-transplant dynamics and clinical significance of CMV-specific neutralizing antibodies in kidney transplant recipients treated with T-cell-depleting agents.
    J Infect Dis. 2023 Sep 22:jiad411. doi: 10.1093.
    >> Share

  5. HUANG Y, Tang J, Yu H, Song Q, et al
    Reconsideration of maternal serological testing for predicting congenital CMV infection.
    J Infect Dis. 2023 Sep 21:jiad412. doi: 10.1093.
    >> Share

  6. SADOWSKA-KLASA A, Leisenring WM, Limaye AP, Boeckh M, et al
    Cytomegalovirus Viral Load Threshold to Guide Preemptive Therapy in Hematopoietic Cell Transplant Recipients: Correlation with CMV Disease.
    J Infect Dis. 2023 Sep 8:jiad386. doi: 10.1093.
    >> Share

    July 2023
  7. CHOU S, Alain S, Cervera C, Chemaly RF, et al
    Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.
    J Infect Dis. 2023 Jul 28:jiad293. doi: 10.1093.
    >> Share

    June 2023
  8. PARIS R, Apter D, Boppana S, D'Aloia M, et al
    Incidence of Cytomegalovirus Primary and Secondary Infection in Adolescent Girls: Results From a Prospective Study.
    J Infect Dis. 2023 Jun 21:jiad182. doi: 10.1093.
    >> Share

    April 2023
  9. ALVAREZ-HEREDIA P, Reina-Alfonso I, Dominguez-Del Castillo JJ, Gutierrez-Gonzalez C, et al
    Accelerated T cell immunosenescence in CMV-seropositive individuals after SARS-CoV-2 infection.
    J Infect Dis. 2023 Apr 26:jiad119. doi: 10.1093.
    >> Share

    March 2023
  10. HASTIE E, Moser C, Sun X, Lennox J, et al
    Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding during Suppressive Antiretroviral Therapy.
    J Infect Dis. 2023 Mar 7:jiad060. doi: 10.1093.
    >> Share

    November 2022
  11. PERERA MR, Greenwood EJ, Crozier TW, Elder EG, et al
    Human cytomegalovirus infection of epithelial cells increases SARS-CoV-2 superinfection by upregulating the ACE2 receptor.
    J Infect Dis. 2022 Nov 21:jiac452. doi: 10.1093.
    >> Share

    September 2022
  12. CHOU S, Song K, Wu J, Bo T, et al
    Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection.
    J Infect Dis. 2022;226:576-584.
    >> Share

    August 2022
  13. SANTOS BRAVO M, Plault N, Sanchez-Palomino S, Rodriguez C, et al
    Genotypic and phenotypic study of antiviral resistance mutations in refractory cytomegalovirus infection.
    J Infect Dis. 2022 Aug 22. pii: 6672993. doi: 10.1093.
    >> Share

  14. HARNOIS MJ, Dennis M, Stohr D, Valencia SM, et al
    Elite neutralizers of human cytomegalovirus are characterized by high magnitude plasma IgG responses against multiple glycoprotein complexes.
    J Infect Dis. 2022 Aug 16. pii: 6667625. doi: 10.1093.
    >> Share


  15. Correction to: Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral Therapy.
    J Infect Dis. 2022 Aug 11. pii: 6661279. doi: 10.1093.
    >> Share

    July 2022
  16. SEMMES EC, Permar SR
    Human cytomegalovirus infection primes fetal NK cells for Fc-mediated anti-viral defense.
    J Infect Dis. 2022 Jul 25. pii: 6649429. doi: 10.1093.
    >> Share

  17. VAABEN AV, Levan J, Nguyen CBT, Callaway PC, et al
    In Utero Activation of NK Cells in Congenital CMV Infection.
    J Infect Dis. 2022 Jul 25. pii: 6649436. doi: 10.1093.
    >> Share

    May 2022
  18. KUA KP, Chongmelaxme B, Lee S
    Association between cytomegalovirus infection and tuberculosis disease: A systematic review and meta-analysis of epidemiological studies.
    J Infect Dis. 2022 May 4. pii: 6580085. doi: 10.1093.
    >> Share

    April 2022
  19. PERMAR SR, Kaur A, Fruh K
    De-risking human cytomegalovirus vaccine clinical development in relevant preclinical models.
    J Infect Dis. 2022 Apr 13. pii: 6567687. doi: 10.1093.
    >> Share

  20. LI J, Wellnitz S, Chi XS, Yue Y, et al
    Horizontal transmission of cytomegalovirus in a rhesus model despite high-level, vaccine-elicited neutralizing antibody and T cell responses.
    J Infect Dis. 2022 Apr 12. pii: 6567520. doi: 10.1093.
    >> Share

    February 2022
  21. RAFFERTY H, Murray MJ, Tam JCH, Macfarlane A, et al
    Are the patterns of cytomegalovirus viral load seen after solid organ transplantation affected by circadian rhythm?
    J Infect Dis. 2022 Feb 20. pii: 6532605. doi: 10.1093.
    >> Share

  22. PAVLINAC P, Singa B, Huang ML, Shrestha L, et al
    Cytomegalovirus viremia predicts post-discharge mortality in Kenyan HIV-exposed uninfected children.
    J Infect Dis. 2022 Feb 13. pii: 6527814. doi: 10.1093.
    >> Share

  23. ALANIO C, Verma A, Mathew D, Gouma S, et al
    Cytomegalovirus latent infection is associated with an increased risk of COVID-19-related hospitalization.
    J Infect Dis. 2022 Feb 2. pii: 6520490. doi: 10.1093.
    >> Share

    November 2021
  24. YATES TA, Griffith GJ, Morris TT
    Human Cytomegalovirus and Risk of Incident Cardiovascular Disease in UK Biobank.
    J Infect Dis. 2021 Nov 23. pii: 6433725. doi: 10.1093.
    >> Share

    October 2021
  25. VERBOEKET SO, Wit FW, Verheij E, van Zoest RA, et al
    Human Immunodeficiency Virus (HIV)-Negative Men Who Have Sex With Men Have Higher CD8+ T-Cell Counts and Lower CD4+/CD8+ T-Cell Ratios Compared With HIV-Negative Heterosexual Men.
    J Infect Dis. 2021;224:1187-1197.
    >> Share

  26. LECUYER R, Issa N, Tessoulin B, Lavergne RA, et al
    Epidemiology and clinical impact of respiratory co-infections at diagnosis of Pneumocystis jirovecii Pneumonia.
    J Infect Dis. 2021 Oct 4. pii: 6380657. doi: 10.1093.
    >> Share

    September 2021
  27. SANTOS BRAVO M, Plault N, Sanchez Palomino S, Mosquera Gutierrez MM, et al
    Phenotype and Genotype Study of Novel C480F Maribavir-Ganciclovir Cross-Resistance Mutation Detected in Hematopoietic Stem Cell and Solid Organ Transplant Recipients.
    J Infect Dis. 2021;224:1024-1028.
    >> Share

    July 2021
  28. HAMILTON EM, Allen NE, Mentzer AJ, Littlejohns TJ, et al
    Human cytomegalovirus and risk of incident cardiovascular disease in UK Biobank.
    J Infect Dis. 2021 Jul 19. pii: 6323934. doi: 10.1093.
    >> Share

  29. POLONI C, Szyf M, Cheishvili D, Tsoukas CM, et al
    Are the healthy vulnerable? Cytomegalovirus seropositivity in healthy adults is associated with accelerated epigenetic age and immune-dysregulation.
    J Infect Dis. 2021 Jul 13. pii: 6320592. doi: 10.1093.
    >> Share

    April 2021
  30. STERN A, Su Y, Dumke H, Fang J, et al
    CMV viral load kinetics predict CMV end-organ disease and mortality after hematopoietic cell transplant (HCT).
    J Infect Dis. 2021 Apr 17. pii: 6232014. doi: 10.1093.
    >> Share

  31. DIOVERTI PRONO MV, Avery RK
    Viral load kinetics: a way to assess cumulative effects of CMV on hematopoietic stem cell transplant recipients.
    J Infect Dis. 2021 Apr 17. pii: 6232022. doi: 10.1093.
    >> Share

    March 2021
  32. SINGH N, Winston DJ, Razonable RR, Lyon GM, et al
    Unexpected CMV replication kinetics in CMV- donor seropositive recipient seronegative liver transplant recipients receiving preemptive antiviral therapy.
    J Infect Dis. 2021 Mar 23. pii: 6182482. doi: 10.1093.
    >> Share

    December 2020
  33. ALTAF M, Lineburg K, Crooks P, Rehan S, et al
    Pre-transplant cytomegalovirus-specific cellular immunity and risk of viral reactivation following lung transplantation: a prospective cohort study.
    J Infect Dis. 2020 Dec 4. pii: 6019998. doi: 10.1093.
    >> Share

    November 2020
  34. DONADEU L, Revilla-Lopez E, Jarque M, Crespo E, et al
    CMV-specific Cell-Mediated Immunity Predicts High level of CMV Replication after Prophylaxis withdrawal in Lung Transplant Recipients.
    J Infect Dis. 2020 Nov 27. pii: 6007492. doi: 10.1093.
    >> Share

  35. IMLAY H, Dasgupta S, Boeckh M, Stapleton RD, et al
    Risk Factors for Cytomegalovirus Reactivation and Association with Outcomes in Critically Ill Adults with Sepsis: A Pooled Analysis of Prospective Studies.
    J Infect Dis. 2020 Nov 7. pii: 5959850. doi: 10.1093.
    >> Share

    October 2020
  36. SLYKER JA, Guthrie B, Pankau M, Tapia K, et al
    Cytomegalovirus and Epstein-Barr virus viremia are associated with HIV DNA levels in the reservoir of Kenyan infants on antiretroviral therapy.
    J Infect Dis. 2020 Oct 16. pii: 5926738. doi: 10.1093.
    >> Share

  37. COX KS, Zhang L, Freed DC, Tang A, et al
    Functional Evaluation and Genetic Evolution of Human T-cell Responses after Vaccination with a Conditionally Replication-Defective Cytomegalovirus Vaccine.
    J Infect Dis. 2020 Oct 8. pii: 5919748. doi: 10.1093.
    >> Share

    July 2020
  38. VIETZEN H, Gorzer I, Honsig C, Jaksch P, et al
    Human Cytomegalovirus (HCMV)-Specific Antibody Response and Development of Antibody-Dependent Cellular Cytotoxicity Against HCMV After Lung Transplantation.
    J Infect Dis. 2020;222:417-427.
    >> Share

    March 2020
  39. GRIFFITHS P, Hughes B
    Choice of Study Populations for Vaccines.
    J Infect Dis. 2020;221.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016